Skip to main content
. 2022 Jun;34(2):149–154. doi: 10.5455/msm.2022.34.149-154

Table 2. Other annual costs of DM management in B&H.

Type of costs Annual costs per patient Percent of affected patients Annual costs for whole B&H population of DM patients
Medication costs (ATC -A10) 157.87 € NA 40,417,530 €
Glucose measuring instruments 0.34 € NA 87,459 €
Accessories for glucose measuring instruments 0.01 € NA 1,487 €
Glucose test stripes 13.39 € NA 3,427,304 €
Costs of complications: diabetic foot 4727.73 € 0.48% 5,759,556 €
Costs of Complications: end-stage renal disease (ESRD) 696.56 € 0.05% 88,394 €
Costs of Complications: heart failure 1268.8 € 4.40% 14,169,057 €
Costs of Complications: painful neuropathy 366.74 € 3.42% 3,183,314 €
Costs of Complications: peripheral vascular disease 2535.18 € 0.27% 1,737,271 €
Costs of Complications: retinopathy 287.76 € 0.56% 408,991 €
Costs of Complications: stable angina 1629.01 € 6.15% 25,426,933 €
Total costs of DM without complications 319.0 € NA 81,580,901 €
Total costs of DM with complications 516.97 € NA 132,354,418 €
Loss of productivity costs 222.0 € NA 56,723,322 €
Total costs of DM in B&H 738.97 € NA 189,077,740 €